title: Antipsychotic polypharmacy does not increase the risk for side effects.
authors.forename: Soma
authors.initials: S
authors.lastname: Ganesan
authors.forename: Ross
authors.initials: R
authors.lastname: Taylor
authors.forename: Kiran
authors.initials: K
authors.lastname: Rabheru
authors.forename: Ian
authors.initials: I
authors.lastname: Forbes
authors.forename: Jane
authors.initials: J
authors.lastname: Dumontet
authors.forename: Ric M
authors.initials: RM
authors.lastname: Procyshyn
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D019338:Polypharmacy; D011618:Psychotic Disorders / Q000188:drug therapy; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents